Arcus Biosciences OverviewArcus Biosciences EBIT
EBIT (Earnings Before Interest and Taxes) analysis for RCUS.
Quarterly EBIT
-$136.00M
↓ 8.8% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$360.00M
↑ 15.69% YoY
Trailing 12 months ending Mar 31, 2026
Arcus Biosciences OverviewEBIT (Earnings Before Interest and Taxes) analysis for RCUS.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026